Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Company to open new headquarters in 2024
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023
The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency
The company sees the business reaching $100mn
Subscribe To Our Newsletter & Stay Updated
